RxDoctor Payments Data

Momodou Jammeh, MD

Vascular Surgery · Milwaukee, WINPI 1467947382

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (38.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Medtronic at 54.1% of the total. 2025 is the largest year on record at $6,445, more than ten times the $186 reported in 2019. Among vascular surgery clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,504in general payments, 2019–2025

Across 87 payments — averaging $155.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$7K
  • Penumbra, Inc.$3K
  • W. L. Gore & Associates, Inc.$1K
  • Inari Medical, Inc.$402
  • Bolton Medical Inc$377
  • Cook Medical LLC$243
  • plus $1K from 10 others

What the payments were for

  • Consulting fees$4,60034%
  • Travel & lodging$2,63620%
  • Food & beverage$5,23339%
  • Education$1,0368%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,504 in reported general payments places this provider in the 90th percentile of 81 vascular surgery providers in Wisconsin.

See all vascular surgery providers in Wisconsin

Medicare billing

Part B allowed, 2024
$52,815
Medicare patients
211
Services billed
382

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban22$16,059

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →